Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
SUNation Energy Announces Initial Closing of Registered Direct Offering Generating Gross Proceeds of $15 Million
-
Cibus Announces Leadership Change and CEO Succession Plan
-
Astrotech Creates New Subsidiary EN-SCAN, Inc.
-
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval
-
Inuvo, Inc. Announces Charles D. Morgan's Retirement; Rob Buchner Joins Board
-
Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company’s Continuous Glucose Monitoring Technology
-
Nightfood Holdings, Inc. (NGTF) Provides Update on Strategic Acquisitions and Expansion for 2025
-
SEALSQ to Present at Cantor Global Technology Investor Conference
-
Jamf Announces Upcoming Conferences Participation
-
Bay State Milling Expands Oats Portfolio with Launch of PurelySown™ Purity Protocol Gluten-Free Oats
-
The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease
-
transcosmos wins Certified Partner award under CAPiCO certified partner program by YRGLM
-
KE Holdings Inc. Upgraded to ‘A’ in MSCI ESG Rating
-
Nordic Fibreboard AS unaudited financial report for the Q4 and 12 months of 2024
-
NeuralCure AI Partners with Leading Medical Imaging Provider to Enhance AI-Powered Diagnostic Support for Physicians
-
FRO – Q4 2024 Presentation
-
Canaf Reports Financial Results for Fiscal Year 2024
-
Costa Rica Maintains Strong FDI Momentum: 73 Investment Projects with CINDE's Strategic Support
-
Expanse (GMGI) Completes 5th U.S. Sweepstakes Integration, Now Live with Yotta
-
David Rawlinson and QVC Group, Inc. Agree to New Three-Year Deal
-
CHMP recommends EU approval of Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma
-
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibito
-
HostColor Expands Edge Bare Metal Server Hosting Options
-
The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU
-
University of the People Awarded WASC Accreditation
-
Bitget Spreads Kindness This Ramadan by Providing 100,000 Meals to Those in Need
-
Kennel Connection Marks Four Years with 100GROUP, Advancing FinTech for Pet Care Businesses
-
Travelers Reveal Their Top Summer Travel Concerns
-
Safe & Green Holdings Corp. Regains Compliance with Nasdaq Continued Listing Requirements
-
nLIGHT, Inc. Announces Upcoming Investor Events
-
Safe & Green Holdings Corp. Regains Compliance with Nasdaq Continued Listing Requirements
-
Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration
-
FinaMill Goes Bolder and Brighter With New Branding, New Tabletop Models, More Powerful Motors, and a New Color Palette at The Inspired Home Show
-
Guanajuato Silver Completes Development to High Grade Santo Nino Vein at San Ignacio
-
enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25
-
Twin Vee PowerCats Announces the Official Launch of BoatsForSale.com
-
Josip Heit, Founder of GSB Germany in an Interview on the Future of the Fintech Industry
-
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025
-
MWC 2025: Amdocs Opens GenAI-Focused Experience Lab in North America, Showcasing Leading-Edge Generative AI Capabilities that Fuel Business Growth
-
MWC 2025: Communications Service Providers Missing Out on $24B of B2B Revenue Due to Inefficiencies, Fragmented Systems, and Skill Gaps across Customer Lifecycle, Amdocs Research Finds
-
Great Tea Road Retracing: A Journey Along the Ancient Tea Trade Route
-
MUTANT SAYS "GET YOUR GREENS FOR BIGGER GAINS"
-
MGP Ingredients, Inc. (MGPI) Notice: Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders
-
Corcel Announces Non-Brokered Private Placement
-
AnalytixInsight Announces Restatement of Financial Statements
-
Quest Critical Metals Announces Non-Brokered Private Placement Offering of up to $1,500,000
-
Plata Latina Appoints Lance Newman and Rod Pace to Its Board of Directors
-
Golden Arrow Resources: Invitation to PDAC 2025 Booth 2924
-
Alliance Witan PLC - Net Asset Value
-
Jasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Academy of Dermatology (AAD) Annual Meeting
